Jim Simons Karuna Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$176.32 - $240.22 $18.2 Million - $24.8 Million	-103,200 Reduced 90.61%	10,700 $2.32 Million
Q1 2023 May 12, 2023	SELL	$161.33 - $204.36 $30.7 Million - $38.8 Million	-190,100 Reduced 62.53%	113,900 $20.7 Million
Q4 2022 Feb 13, 2023	SELL	$191.53 - $236.82 $8.81 Million - $10.9 Million	-46,000 Reduced 13.14%	304,000 $59.7 Million
Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $40 Million - $89.6 Million	323,000 Added 1196.3%	350,000 $78.7 Million
Q2 2022 Aug 12, 2022	BUY	$93.97 - $143.33 $2.54 Million - $3.87 Million	27,000 New	27,000 $3.42 Million
Q1 2022 May 13, 2022	SELL	$98.9 - $132.37 $336,260 - $450,058	-3,400 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$110.64 - $159.4 $376,176 - $541,960	3,400 New	3,400 $445,000
Q2 2020 Aug 13, 2020	SELL	$62.14 - $117.21 $1.74 Million - $3.28 Million	-28,000 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$60.41 - $115.92 $1.69 Million - $3.25 Million	28,000 New	28,000 $2.02 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.